UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Oxinas Partners Wealth Management LLC

Oxinas Partners Wealth Management LLC lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 7.8% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,530 shares of the healthcare conglomerate’s stock after selling 129 shares during the period. Oxinas Partners Wealth Management LLC’s holdings in UnitedHealth Group were worth $757,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the business. Richelieu Gestion SA acquired a new position in shares of UnitedHealth Group in the fourth quarter worth $26,000. CGC Financial Services LLC increased its stake in shares of UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares during the last quarter. True Wealth Design LLC acquired a new position in UnitedHealth Group during the fourth quarter worth $31,000. LFA Lugano Financial Advisors SA increased its position in UnitedHealth Group by 148.1% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 40 shares during the last quarter. Finally, Transcendent Capital Group LLC acquired a new position in UnitedHealth Group during the fourth quarter worth $40,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE UNH opened at $498.13 on Wednesday. The firm has a market cap of $458.47 billion, a price-to-earnings ratio of 30.45, a PEG ratio of 1.48 and a beta of 0.60. The company has a 50 day moving average of $498.40 and a 200-day moving average of $501.35. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company’s revenue was up 8.6% on a year-over-year basis. During the same quarter last year, the business posted $6.26 earnings per share. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 27.55 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, June 17th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.69%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

Analysts Set New Price Targets

UNH has been the topic of several analyst reports. TD Cowen lowered their target price on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th. Deutsche Bank Aktiengesellschaft upped their price target on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a report on Friday, April 19th. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Friday, June 28th. Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a report on Monday, April 8th. Finally, Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Three research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus target price of $579.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.